Clinical Trial Update: Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial update describing switching HIV treatment from the current suppressive regimen to a regimen including raltegravir and atazanavir due to side effec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)
• REYATAZ (atazanavir)

Snippet

Sponsor: Peter J. Ruane, M.D., Inc. | Conditions: HIV Infections | Phase 4 | Status: UNKNOWN